Here we discuss the advantages and pitfalls of HIPEC in advanced ovarian cancer, as well as current data and ongoing prospective trials.
Oliver Zivanovic, MD, PhD
Advertisement
Articles by Oliver Zivanovic, MD, PhD
Advertisement
Latest Updated Articles
- Intraoperative Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer
Published: September 15th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
3
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
4
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer
5
